Literature DB >> 11252689

Eighteen years follow-up study of the clinical manifestations and progression of Dupuytren's disease.

K G Gudmundsson1, R Arngrimsson, T Jónsson.   

Abstract

OBJECTIVE: To evaluate the clinical manifestations and progression of Dupuytren's disease.
METHODS: In 1981-82 a total of 1297 men were examined for Dupuytren's disease, and of these 19.2% had the disease. In 1999 those with signs of the disease in 1981-82 were invited for a follow-up study. As controls symptom free individuals from the study in 1981-82 were invited.
RESULTS: A total of 53 individuals from the control group had developed Dupuytren's disease in 1999. Men with palmar nodules/fibrous cord in 1981-82 were more likely to develop contracted fingers than those without Dupuytren's disease. Patients with young age at disease onset more often required operations than those with later onset. Of the men who had been operated 70% still had finger contractures in 1999.
CONCLUSION: The incidence of Dupuytren's disease is high in elderly men. Dupuytren's disease is progressive in nature and most operated patients have recurrent finger contractures.

Entities:  

Mesh:

Year:  2001        PMID: 11252689     DOI: 10.1080/030097401750065292

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  11 in total

Review 1.  Management of Dupuytren's disease--clear advice for an elusive condition.

Authors:  A Bayat; D A McGrouther
Journal:  Ann R Coll Surg Engl       Date:  2006-01       Impact factor: 1.891

2.  Calcium-dependent signaling in Dupuytren's disease.

Authors:  Josef G Hadeed; Jennifer E Bond; M Angelica Selim; Andrew Bergeron; L Scott Levin; Howard Levinson
Journal:  Hand (N Y)       Date:  2010-12-15

3.  Anti-tumour necrosis factor therapy for early-stage Dupuytren's disease (RIDD): a phase 2b, randomised, double-blind, placebo-controlled trial.

Authors:  Jagdeep Nanchahal; Catherine Ball; Ines Rombach; Lynn Williams; Nicola Kenealy; Helen Dakin; Heather O'Connor; Dominique Davidson; Paul Werker; Susan J Dutton; Marc Feldmann; Sarah E Lamb
Journal:  Lancet Rheumatol       Date:  2022-04-29

4.  Periostin differentially induces proliferation, contraction and apoptosis of primary Dupuytren's disease and adjacent palmar fascia cells.

Authors:  Linda Vi; Lucy Feng; Rebecca D Zhu; Yan Wu; Latha Satish; Bing Siang Gan; David B O'Gorman
Journal:  Exp Cell Res       Date:  2009-07-18       Impact factor: 3.905

5.  Blue light irradiation and its beneficial effect on Dupuytren's fibroblasts.

Authors:  Julia Krassovka; Annika Borgschulze; Benita Sahlender; Tim Lögters; Joachim Windolf; Vera Grotheer
Journal:  PLoS One       Date:  2019-01-11       Impact factor: 3.240

Review 6.  Recent advances in the understanding of Dupuytren's disease.

Authors:  Thomas Layton; Jagdeep Nanchahal
Journal:  F1000Res       Date:  2019-02-28

7.  Type-1 Collagen differentially alters beta-catenin accumulation in primary Dupuytren's Disease cord and adjacent palmar fascia cells.

Authors:  Linda Vi; Anna Njarlangattil; Yan Wu; Bing Siang Gan; David B O'Gorman
Journal:  BMC Musculoskelet Disord       Date:  2009-06-19       Impact factor: 2.362

Review 8.  Systematic review of non-surgical treatments for early dupuytren's disease.

Authors:  Catherine Ball; David Izadi; Liaquat Suleman Verjee; James Chan; Jagdeep Nanchahal
Journal:  BMC Musculoskelet Disord       Date:  2016-08-15       Impact factor: 2.362

Review 9.  What do we know about managing Dupuytren's disease cost-effectively?

Authors:  Melina Dritsaki; Oliver Rivero-Arias; Alastair Gray; Catherine Ball; Jagdeep Nanchahal
Journal:  BMC Musculoskelet Disord       Date:  2018-01-25       Impact factor: 2.362

10.  Study protocol: A multi-centre, double blind, randomised, placebo-controlled, parallel group, phase II trial (RIDD) to determine the efficacy of intra-nodular injection of anti-TNF to control disease progression in early Dupuytren's disease, with an embedded dose response study.

Authors:  Jagdeep Nanchahal; Catherine Ball; Jennifer Swettenham; Susan Dutton; Vicki Barber; Joanna Black; Bethan Copsey; Melina Dritsaki; Peter Taylor; Alastair Gray; Marc Feldmann; Sarah Lamb
Journal:  Wellcome Open Res       Date:  2017-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.